Dr. Mark A. Rhodes, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6 Steptoe Cir, Ely, NV 89301 Phone: 775-289-3612 Fax: 775-289-6423 |
Valerie J Miller, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Valerie J Miller Pllc, 696 Aultman St, Ely, NV 89301 Phone: 702-524-3307 |
Nasir Uddin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Steptoe Cir, Ely, NV 89301 Phone: 775-289-2424 Fax: 775-289-6423 |
Ben Harris, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Avenue H, Ely, NV 89301 Phone: 775-289-3001 |
Gary M Seigel, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Steptoe Cir, Ely, NV 89301 Phone: 775-289-2424 Fax: 775-289-6423 |
News Archive
Practical medical advice that works in the "real world" may more effectively prevent cardiovascular disease in women than recommendations based only on findings in clinical research settings, according to the 2011 update to the American Heart Association's cardiovascular disease prevention guidelines for women.
Research is underway at Rochester Institute of Technology that will give scientists a better understanding of the vitreous humor, or gel, that fills the eye and could lead to advances in the treatment of vision disorders, drug delivery and eye surgery.
Feeding premature babies mostly breast milk during the first month of life appears to spur more robust brain growth, compared with babies given little or no breast milk.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
› Verified 4 days ago